These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22949917)

  • 1. Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.
    Altemtam N; Nahas ME; Johnson T
    Nephron Extra; 2012 Jan; 2(1):219-32. PubMed ID: 22949917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease.
    Miyata KN; Zhao XP; Chang SY; Liao MC; Lo CS; Chenier I; Ethier J; Cailhier JF; Lattouf JB; Troyanov S; Chiasson JL; Ingelfinger JR; Chan JSD; Zhang SL
    Transl Res; 2020 Mar; 217():1-10. PubMed ID: 31794697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
    Cakirca G; Turgut FH
    Iran J Kidney Dis; 2018 Oct; 12(5):299-304. PubMed ID: 30367022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.
    Bieniaś B; Sikora P
    Dis Markers; 2020; 2020():9520309. PubMed ID: 32670438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
    Lafuma C; El Nabout RA; Crechet F; Hovnanian A; Martin M
    J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinases in Diabetic Kidney Disease.
    Garcia-Fernandez N; Jacobs-Cachá C; Mora-Gutiérrez JM; Vergara A; Orbe J; Soler MJ
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32046355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
    Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM
    Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade.
    Mora-Gutiérrez JM; Rodríguez JA; Fernández-Seara MA; Orbe J; Escalada FJ; Soler MJ; Slon Roblero MF; Riera M; Páramo JA; Garcia-Fernandez N
    Sci Rep; 2020 Jan; 10(1):26. PubMed ID: 31913319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes.
    Salem NA; Ismail WM; Hendawy SR; Abdelrahman AM; El-Refaey AM
    Eur J Pediatr; 2024 Jun; ():. PubMed ID: 38884820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
    Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
    BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
    Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
    J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.
    Afkarian M; Hirsch IB; Tuttle KR; Greenbaum C; Himmelfarb J; de Boer IH
    Physiol Rep; 2014; 2(5):e12010. PubMed ID: 24793984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury.
    Mazanowska O; Kamińska D; Krajewska M; Zabińska M; Kopeć W; Boratyńska M; Chudoba P; Patrzalek D; Klinger M
    Transplant Proc; 2011 Oct; 43(8):3000-3. PubMed ID: 21996210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary soluble CD90 predicts renal prognosis in patients with diabetic kidney disease.
    Wu L; Chang DY; Zhang LX; Chen M; Zhao MH
    Ann Transl Med; 2021 Feb; 9(4):282. PubMed ID: 33708909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.